Toggle Dropdown
Groups
Announcements
Projects
Ideas
Welcome guest
Log in
Practice
My Requests
All Requests
Drill Partners
Digital games
Projects
Goals
Loading
Loading...
0
0
Exclusive: CEO of Ozempic prescription startup Calibrate steps down as investors eye ‘rapid down-sizing’ of consumer business - Fortune
+ 12 more
10/30/23 at 9:28pm
Organization
Fortune
Author
Jessica Mathews
38 words
0
Comments
Calibrate CEO Isabelle Kenyon is stepping down as chief executive and will no longer oversee day-to-day operations.
Business & Industrial
Investing
Fortune Calibrate
prescription startup
You are the first to view
https://fortune.com/2023/10/30/calibrate-ozempic-leadership-changes-consumer/
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...